By using rat liver perfusion under one-pass conditions with a single pulse of horseradish peroxidase (HRP), the biliary output of HRP was used as an indicator of paracellular permeability change caused by the cholestatic compound oestradiol 17fl-glucuronide (E17G). Since E17G reduced bile flow, we have also used, during the assessment of junctional permeability after E17G treatment, the choleretic compound taurodehydrocholate to enhance bile flow back to control levels. At both low and restored bile flow rates, the acute administraton of E17G (3.4,#mol) increased the HRP peak height, thereby indicating that one of the hepatotoxic actions of E17G is to increase the permeability of hepatic tight junctions. The action of E17G in affecting bile acid secretion and biliary volume are also explored.
INTRODUCTION
Intrahepatic cholestasis is observed in some women during the last trimester of pregnancy, when plasma oestrogen concentrations are high, sometimes in women using oral steroidal contraceptives and also in animals treated with high doses of oestrogens. It is thought to be due to the effects ofincreased amounts ofminor oestrogen metabolites being present under such circumstances, particularly D-ring glucuronide conjugates of oestrogens, which show potent dose-dependent reversible cholestatic properties (Meyers et al., 1980 (Meyers et al., , 1981 Vore, 1981; Vore et al., 1983; Vore & Slikker, 1985) .
The mechanism(s) of the toxic action of these compounds are still little understood. A number of possibilities have been advanced including: (i) reduction in (Na++K+)-dependent ATPase activity, (ii) decrease in bile acid synthesis, (iii) decrease in bile acid transport, (iv) change in the plasma-membrane lipid composition, and (v) an alteration in the junctional permeability (Forker, 1969; Cooper, 1977; Davis et al., 1978; Meyers et al., 1981; Elias et al., 1983) .
Although an involvement of hepatic tight junctions has been suggested as a contributor to cholestasis caused by oestrogen metabolites (Forker, 1969; Peterson & Fujimoto, 1977; Vore, 1981 Vore, , 1987 Bradley, 1982; Elias et al., 1983; Aldinolfi et al., 1984; Iqbal et al., 1984 Iqbal et al., , 1985 Jaeschke et al., 1987a) , contradictory results have been obtained by others (Meyers et al., 1980; Jaeschke et al., 1983 Jaeschke et al., , 1987b (Lorenzini et al., 1986) ; only recently has an attempt been made to take an account of the transcytotic contribution (Jaeschke et al., 1987a) ; (ii) the bile/plasma (B/P) ratio is also influenced by the bile flow rate (see Forker, 1969; Elias et al., 1983) , i.e. a depression in this flow rate may enhance the diffusion rate of the inert compound, artificially increasing the B/P ratio.
When isolated perfused liver was pulsed under singlepass conditions with the marker compound horseradish peroxidase (HRP), the height of the first peak of the biliary HRP output appeared to be a good indicator of junctional permeability (Lowe et al., 1985) and has been used in a number of recent studies involving changes in junctional permeability (Kan & Coleman, 1986 Lowe et al., 1988) .
In the present work we have studied the effect of the cholestatic compound, oestradiol 17,f-glucuronide 
Methods
Male Wistar rats, approx. 250 g body wt. each, were used throughout the study. The bile duct was cannulated using PP1O tubing during pentobarbital anaesthesia. The liver was isolated in situ as described by Hems et al. (1966) and perfused with 150 ml of Krebs-Ringer bicarbonate solution (Krebs & Henseleit, 1932) containing 1 % (w/v) BSA, 5 mM-glucose, 1.2 mM-CaCl2, a physiological amino acid mixture (see Barnwell & Coleman, 1983 ) and 20 % (v/v) At 15 min after the injection of E17G, the liver perfusion was converted to single-pass conditions, and 3 mg of HRP, dissolved in 1 ml of Krebs-Ringer bicarbonate solution, was then infused, within 1 min, into the liver at the same entry point as the drug injection (Lowe et al., 1985; Kan & Coleman, 1988) .
Bile was collected into preweighed tubes, and the flow rates were determined gravimetrically (assuming a density of 1 g/ml) throughout each experiment. The HRP in the collected bile was assayed spectrophotometrically as described by Gallati & Pract (1975) , and the location and height of the first peak of biliary HRP was identified. Further details are given in the legend to Fig. 3 (below) .
Bile acids in bile were assayed by using hydroxysteroid dehydrogenase (EC 1.1.1.50) as described by Coleman et al. (1979) . In the case of experiments with cyclobutyrol, details are given in the legend to Fig. 2 (below) . (Fig. la) is to cause a substantial reduction in flow. Since most of the bile acid pool in the liver had been depleted by the prior perfusion conditions, the flow reduction caused by E17G is therefore largely bile-acid-independent. Reduction of bile-acid-independent flow in other experimental designs has been observed by other groups of workers (Meyers et al., 1980; Iqbal et al., 1984) . Infusion of TDHC increased the control bile flow by 12,u1/min (Fig. lb) , but the subsequent administration of E17G then substantially reduced the flow back to the untreated control level. The fall in this case was greater than under saline-infusion conditions, indicating that the portion of flow stimulated by TDHC was reduced (i.e. a bile-acid-dependent flow), in addition to reducing the flow independent of bile acids. This is supported by the concomitant fall in secretion of bile acids (Figs. 1c and Id); in the case of TDHC, this is largely the hydroxy metabolites of TDHC, since hydroxysteroid dehydrogenase does not measure TDHC directly.
The fall in bile flow is partially reversed 15 min after E17G administration (see also Aldinolfi et al., 1984) . This reversal coincides with the restoration of bile-acid secretion (TDHC metabolites) (Fig. ld) . Appreciable flow reduction, however, still remains after this point (Fig. lb) and is thus likely to be due to the continuing inhibition of the flow independent of bile acids. Administration of E17G at a high dosage caused complete biliary reduction in perfused livers and in bile-fistula rats (results not shown), partly indicating that both the bile-aciddependent flow and the bile-acid-independent flow could be affected. Meyers et al. (1981) have noted a structural similarity between D-ring steroidal glucuronides and bile acids, which led to the suggestion that cholestatic steroids may specifically inhibit the bile-acid carrier. In the present experiments with the choleretic anion CB [see Fig. 2 and also Roquet & Jousse (1960) ], and in which most of the endogenous bile-salt pool has been depleted before CB infusion, the portion of bile flow stimulated by this nonbile acid choleretic was severely reduced. Thus E,7G, in addition to its inhibitory effects on the bile-acid-transport system, may also interfere with other anion transports which may play a part in generating the total flow.
Effect on junctional permeability
In Vore's (1987) review, a word of caution on the possibility of junctional permeability change caused by oestrogens was sounded in relation to B/P equilibrium measurement with high-molecular-mass markers, since changes in the relative contributions of paracellular movement and transcellular vesicular transport to the B/P ratio may be subject to differential change. By using the present method of HRP peak height, however, the contribution of vesicular transcytosis has been thereby eliminated, and thus the permeability change of the junction is brought into clearer focus. The use of a choleretic compound, e.g. TDHC, to circumvent the problem of the influence of low flow rate on permeability studies has beef outlined in the Tntroduction.
Thus at both low and restored bile flow rates (Figs.   3a and 3b ), an increase in HRP peak height was observed subsequent to E17G administration (Figs. 3c and 3d) , strongly indicating that an increase in junctional permeability has been caused by exposure to E,7G. Increase in junctional permeability therefore appears to be a feature of cholestasis caused by E17G.
Although increase in permeability of hepatic tight junctions is evident after E17G, it is not yet clear, however, whether bile flow reduction is a direct consequence, or independent, of an increase in junctional permeability. A regurgitation of osmotically active anions through 'leaky' junctions, resulting in reduction of osmotic water, may be a possible mechanism of flow reduction (Elias & Boyer, 1978) . In contrast, however, other studies also have indicated that increase in junctional permeability may not directly lead to flow reduction: (i) increase in junctional permeability during early 1-naphthyl isothiocyanate pretreatment occurs without flow reduction (Kan & Coleman, 1986) ; (ii) low bile flow rates precede junctional-permeability change in rats treated with oestradiol valerate (Jaeschke et al., 1987b) . It thus seems that permeability increase is not concomitant with volume change and, therefore, junctional-permeability change and bile-volume change may be unrelated. In another recent report, other potential causes of E17G-induced cholestasis, e.g. (Na' + K+)-dependent ATPase activity and membrane fluidity, have also been shown to be independent of the volume reduction (Smith & Gordon, 1988) .
The higher junctional permeability seen in E17G-treated livers infused with TDHC, as compared with the saline control, is of some interest. This choleretic compound did not appear to affect the junctional permeability alone, as evidenced by the control (Fig. 1) , and thus the effect is to enhance the permeability effect after E17G treatment. In a study by Utili et al. (1985) , it was observed that TDHC did not affect the excretion of E,7G into bile, and thus it is unlikely that the enhancement of HRP peak height is due to a reduction in the excretion rate of E,7G from the liver, thereby prolonging its presence. Moreover, in preliminary experiments with Vol. 261 . Bile flow and HRP in the bile were measured, and the location of the first peak was identified. The shapes of the first peaks were similar, but the time at which the peak height occurred varied slightly, by one collection tube, i.e. 5+2 min. At higher flow rates the peak was reached in less than 5 min and at lower flow rates at more than 5 min. These small differences in peak time are thought to be a consequence of the difference in bile flow rates. In spite of these small differences in location, the peak height is still a good reflection of the area under the peak. Open columns represent DMSO controls (n = 3); hatched columns represent E17G treatment (n = 4) and bars represent S.E.M.
another choleretic compound, namely norursodeoxycholate, junctional permeability was increased to the same level as that observed with TDHC.
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